Literature DB >> 2169397

Defective insulin receptor function in down-regulated HepG2 cells.

J F Williams1, J M Olefsky.   

Abstract

Insulin receptors on the surface of down-regulated HepG2 cells were studied, and multiple defects of receptor function were demonstrated. Insulin treatment led to a 58% decrease in cell surface receptor number, and the remaining receptors exhibited a 50% decrease in insulin internalization and degradation on a per receptor basis. Down-regulated cells internalized 36% of receptors photolabeled with 125I-NAPA-insulin vs. 56% of labeled receptors in control cells, indicating a 40% decrease in ligand-mediated receptor internalization. Total cellular receptors purified from down-regulated cells by wheat germ affinity chromatography demonstrated a 20% decrease in maximal autophosphorylation. Assessment of autophosphorylation of cell surface receptors in intact cells by restimulation of cells with insulin at 12 C (a temperature nonpermissive for receptor recycling), followed by immunoblotting with antiphosphotyrosine antibodies revealed a decrease of approximately 70% in insulin-stimulated autophosphorylation compared with controls. This method also revealed a comparable decrease in insulin-stimulable tyrosine phosphorylation of pp185, a putative endogenous substrate. When receptors were stimulated to undergo autophosphorylation with 125I-NAPA-insulin in intact cells and then solubilized, only 11% of 125I-NAPA-insulin receptor complexes from down-regulated cells were immunoprecipitated with antiphosphotyrosine antibodies compared with 35% of labeled control receptors. These results indicate that treatment with high concentrations of insulin results in the accumulation on the cell surface of a population of receptors that display multiple functional abnormalities. This probably results from preferential internalization and degradation of kinase-competent insulin receptors causing an accumulation of kinase-incompetent receptors on the cell surface. These receptors may in part be responsible for the postbinding defects in insulin action observed in down-regulated cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169397     DOI: 10.1210/endo-127-4-1706

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Insulin binding to isolated hepatocytes of Atlantic salmon and rainbow trout.

Authors:  E M Plisetskaya; E Fabbri; T W Moon; J Gutiérrez; C Ottolenghi
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

2.  Correlation of alpha-fetoprotein expression in normal hepatocytes during development with tyrosine phosphorylation and insulin receptor expression.

Authors:  L Khamzina; P Borgeat
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

3.  Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.

Authors:  Lei Hao; Kyoko Ito; Kuan-Hsun Huang; Sudathip Sae-tan; Joshua D Lambert; A Catharine Ross
Journal:  Metabolism       Date:  2014-06-21       Impact factor: 8.694

4.  Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects.

Authors:  L Frittitta; G Grasso; M E Munguira; R Vigneri; V Trischitta
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

5.  Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus.

Authors:  H Kanety; S Moshe; E Shafrir; B Lunenfeld; A Karasik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.

Authors:  F Anfosso; N Chomiki; M C Alessi; P Vague; I Juhan-Vague
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 7.  Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.

Authors:  I Juhan-Vague; M C Alessi; P Vague
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

8.  Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects.

Authors:  G Grasso; L Frittitta; M Anello; P Russo; G Sesti; V Trischitta
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

9.  Combined Use of Astragalus Polysaccharide and Berberine Attenuates Insulin Resistance in IR-HepG2 Cells via Regulation of the Gluconeogenesis Signaling Pathway.

Authors:  Zhu-Jun Mao; Min Lin; Xin Zhang; Lu-Ping Qin
Journal:  Front Pharmacol       Date:  2019-12-23       Impact factor: 5.810

10.  lncRNA-mRNA competing endogenous RNA network in IR-hepG2 cells ameliorated by APBBR decreasing ROS levels: a systematic analysis.

Authors:  Min Lin; Zhu-Jun Mao
Journal:  PeerJ       Date:  2020-02-24       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.